Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation

By Lohmann R.   Langrehr J.M.   Klupp J.   Neumann U.   Guckelberger O.   Muller A.R.   Nussler N.C.   Jonas S.   Lang M.   Settmacher U.   Bechstein W.-O.   Neuhaus P.J.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 380-380

Elsevier

Access to resources Recommend Favorite

Comparison of Quadruple Induction Including ATG or IL-2R Antibody With FK506-Based Therapy After Liver Transplantation

By Langrehr J.M.   Schneller A.   Guckelberger O.   Lohmann R.   Neumann U.   Jonas S.   Klupp J.   Settmacher U.   Knoop M.   Bechstein W.O.   Neuhaus P.J.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1439-1440

Elsevier

Access to resources Recommend Favorite

Tacrolimus (FK506) Is Superior to Cyclosporine in Liver Transplantation

By Busuttil R.W.   Holt C.D.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 534-538

Elsevier

Access to resources Recommend Favorite

FK 506 as Primary Immunosuppressive Therapy in Renal Transplantation

By Preston R.   Ball S.   Cairns T.   Contis J.   Hakim N.   Palmer A.   Papalois V.   Taube D.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1214-1215

Elsevier

Access to resources Recommend Favorite

Tacrolimus (FK506)-Based Dual Versus Triple Therapy Following Liver Transplantation

By Samuel D.   Bismuth H.   Boillot O.   Ducerf C.   Baulieux J.   Gugenheim J.   Baldini E.   Launois B.   Messner M.   Wolf P.   Ellero E.   Domergue J.   Pageaux J.   Cherqui D.   Duvoux C.   Durand F.   Belghiti J.   Calmus Y.   Massault P.P.   Neau-Cransac M.   Saric J.   LeTreut Y.   Campan P.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1394-1396

Elsevier

Access to resources Recommend Favorite